Elecsys pTau181 Blood Test Gains European Approval for Alzheimer Disease Diagnosis
According to a new announcement, Roche’s Elecsys pTau181 test, a blood test geared to rule out Alzheimer disease…
Phase 2 Trial of Posdinemab Reveals Racial Differences in Screen Failure for Early Alzheimer Disease
Janice Wong, lead author and senior medical leader in neuroscience at Johnson & Johnson Preliminary data from the…
Dementia Often Goes Undiagnosed for Over 3 Years
Key Questions Answered: Q: How long does it typically take to diagnose dementia?A: On average, 3.5 years from…
Nicotinamide Riboside Shows Effects on Hippocampal Features but Not Improved Memory
New data from a 12-week, double-blind, randomized phase 2 trial showed that nicotinamide riboside (NR) supplementation was safe…
MRI Analysis Shows Brain Morphological Changes in Patients With Breast Cancer and Chemotherapy-Related Cognitive Impairment
Paul Edison, MD, PhD (Credit: Imperial College London) A newly presented study involving patients with breast cancer treated…
DNA Reveal Multiple Sclerosis Risk Before Symptoms Begin
Q: What is this study trying to discover about MS?A: Researchers aim to understand how genetic risk factors…
Trump’s executive order on serious mental illness is a good step
My older brother has schizophrenia. He’s never believed he’s sick, refuses treatment, and has spent years bouncing between…
Anderson family battling 3-year-old’s rare gene disorder | Local News
ANDERSON — An Anderson family is battling their 3-year-old son’s rare brain-development condition. It’s believed that Beau Hanson…
Behavioral Therapy Noninferior to Solifenacin in Managing Overactive Bladder Symptoms of Parkinson Disease
Camille P. Vaughan, MD, MS (Credit: Emory University) In a newly published 12-week randomized noninferiority trial (NCT03149809), findings…